HOME    SEARCH    ABOUT US    CONTACT US    HELP   
           
Rule: 24.159.1011 Prev     Up     Next    
Rule Title: PROHIBITED INTRAVENOUS (IV) THERAPIES
Add to My Favorites
Add to Favorites
Department: LABOR AND INDUSTRY
Chapter: BOARD OF NURSING
Subchapter: Licensed Practical Nurses
 
Latest version of the adopted rule presented in Administrative Rules of Montana (ARM):

Printer Friendly Version

24.159.1011    PROHIBITED INTRAVENOUS (IV) THERAPIES

(1) The practical nurse may not perform any of the following IV therapy procedures:

(a) initiate blood, blood components, and plasma volume expanders;

(b) access or program an implanted IV infusion pump;

(c) insert or remove any IV access device placed for central or midline administration;

(d) manage central venous access devices for hemodynamic monitoring;

(e) perform repair of central or midline venous access devices; or

(f) perform arterial sticks, arterial blood draws, or arterial inline flushes.

(2) The practical nurse may not administer the following IV medications or IV fluids:

(a) oxytocics;

(b) neonatal and pediatric medications;

(c) antineoplastic and chemotherapy drugs;

(d) investigational and experimental drugs;

(e) colloid therapy;

(f) hyperosmolar solutions not appropriate for peripheral venous infusion;

(g) thrombolytic or fibrinolytic agents;

(h) tissue plasminogen activators, or immunoglobulins;

(i) medications for purposes of procedural sedation, moderate sedation, or anesthesia;

(j) medications requiring titration;

(k) medications or fluids via an epidural, intrathecal, intraosseous, umbilical route, or ventricular reservoir; or

(l) medications or fluids via an arteriovenous fistula or graft, except for dialysis per ARM 24.159.1010.

 

History: 37-1-131, 37-8-202, MCA; IMP, 37-1-131, 37-8-202, MCA; NEW, 1997 MAR p. 1176, Eff. 4/8/97; AMD, 1999 MAR p. 2437, Eff. 10/22/99; AMD, 2000 MAR p. 954, Eff. 4/14/00; AMD, 2002 MAR p. 3149, Eff. 11/15/02; TRANS, from Commerce, & AMD, 2006 MAR p. 2035, Eff. 8/25/06; AMD, 2008 MAR p. 1709, Eff. 8/15/08; AMD, 2011 MAR p. 2144, Eff. 10/14/11; AMD, 2021 MAR p. 991, Eff. 8/7/21.


 

 
MAR Notices Effective From Effective To History Notes
24-159-89 8/7/2021 Current History: 37-1-131, 37-8-202, MCA; IMP, 37-1-131, 37-8-202, MCA; NEW, 1997 MAR p. 1176, Eff. 4/8/97; AMD, 1999 MAR p. 2437, Eff. 10/22/99; AMD, 2000 MAR p. 954, Eff. 4/14/00; AMD, 2002 MAR p. 3149, Eff. 11/15/02; TRANS, from Commerce, & AMD, 2006 MAR p. 2035, Eff. 8/25/06; AMD, 2008 MAR p. 1709, Eff. 8/15/08; AMD, 2011 MAR p. 2144, Eff. 10/14/11; AMD, 2021 MAR p. 991, Eff. 8/7/21.
24-159-75 10/14/2011 8/7/2021 History: 37-1-131, 37-8-202, MCA; IMP, 37-1-131, 37-8-202, MCA; NEW, 1997 MAR p. 1176, Eff. 4/8/97; AMD, 1999 MAR p. 2437, Eff. 10/22/99; AMD, 2000 MAR p. 954, Eff. 4/14/00; AMD, 2002 MAR p. 3149, Eff. 11/15/02; TRANS, from Commerce, & AMD, 2006 MAR p. 2035, Eff. 8/25/06; AMD, 2008 MAR p. 1709, Eff. 8/15/08; AMD, 2011 MAR p. 2144, Eff. 10/14/11.
24-159-72 8/15/2008 10/14/2011 History: 37-1-131, 37-8-202, MCA; IMP, 37-1-131, 37-8-202, MCA; NEW, 1997 MAR p. 1176, Eff. 4/8/97; AMD, 1999 MAR p. 2437, Eff. 10/22/99; AMD, 2000 MAR p. 954, Eff. 4/14/00; AMD, 2002 MAR p. 3149, Eff. 11/15/02; TRANS, from Commerce, & AMD, 2006 MAR p. 2035, Eff. 8/25/06; AMD, 2008 MAR p. 1709, Eff. 8/15/08.
8/25/2006 8/15/2008 History: 37-1-131, 37-8-202, MCA; IMP, 37-1-131, 37-8-202, MCA; NEW, 1997 MAR p. 1176, Eff. 4/8/97; AMD, 1999 MAR p. 2437, Eff. 10/22/99; AMD, 2000 MAR p. 954, Eff. 4/14/00; AMD, 2002 MAR p. 3149, Eff. 11/15/02; TRANS, from Commerce, & AMD, 2006 MAR p. 2035, Eff. 8/25/06.
Home  |   Search  |   About Us  |   Contact Us  |   Help  |   Disclaimer  |   Privacy & Security